24 May 2013
Keywords: chmp, asks, angioedema, warning, aliskiren, label, european
Article | 02 March 2009
The European Medicines Agency (EMEA) has recommended adding a contra-indication to the Product Information leaflet for Swiss drug
major Novartis' ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
© 2013 thepharmaletter.com